Skip to main content
Novo's type 2 diabetes drug recommended by EMA panel
12/18/2017

Novo Nordisk's Ozempic, or semaglutide, injection was recommended by the European Medicines Agency's Committee for Medicinal Products for Human Use for glycemic control in patients with type 2 diabetes.

Full Story: